Shanghai Allist Pharmaceuticals Co., Ltd. Stock Price

SHSE:688578 Community·CN¥41.7b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
3 Fair Values set on narratives written by author

Create a narrative

688578 Share Price Performance

CN¥92.60

6.88 (8.03%)

CN¥92.60

6.88 (8.03%)

CN¥92.60

Fri, 1 May 26

Share Pricen/a

688578 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet and undervalued.

0 Risks

4 Rewards

View Full Analysis

Shanghai Allist Pharmaceuticals Co., Ltd. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 5.37
: 96.31%
: 42.57%
: 0%

View Full Analysis

About 688578

Founded: 2004
Employees: 1989
CEO: Jinhao Du
WebsiteView website: www.allist.com.cn

Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally. The company’s lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC). It also develops pralatinib capsules, as well as glerexyl citrate tablets for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.